Skip to navigationSkip to content
Close
The Million Dollar Cancer Treatment: Who Will Pay?

The Million Dollar Cancer Treatment: Who Will Pay?

Read more on The Wall Street Journal

Contributions

  • “Martin Fries’s recent treatment with Yescarta included a 13-day hospital stay, use of several other drugs and a variety of procedures that he anticipates will cost between $750,000 and $1 million.”

    Very dystopian. Low-income people are already more likely to develop certain diseases due to the high

    “Martin Fries’s recent treatment with Yescarta included a 13-day hospital stay, use of several other drugs and a variety of procedures that he anticipates will cost between $750,000 and $1 million.”

    Very dystopian. Low-income people are already more likely to develop certain diseases due to the high costs of healthy food and lack of access to recreational facilities. Now our system is making it impossible for them to get help once they do get sick.

    Unless there is a fundamental change to the present system, we will live in a society that selects for millionaires while allowing middle and low income people to die.

  • With cutting edge cellular treatments like CAR-T, the six figure price of the drug is just the beginning. These treatments bring cost to a whole new level with all the accompanying hospital time and related care and our health care system is still struggling to figure out how to pay for it.

  • So glad these discussions are being had. We are on the path to finding cures in areas of unmet need - we are curing Hep C, curing HIV is in the horizon, and now moving into oncology. The drive to find cures through amazing technology won’t stop. It’s so important to reassess our current healthcare structure

    So glad these discussions are being had. We are on the path to finding cures in areas of unmet need - we are curing Hep C, curing HIV is in the horizon, and now moving into oncology. The drive to find cures through amazing technology won’t stop. It’s so important to reassess our current healthcare structure to ensure patients can appropriately access life saving therapy and that healthcare providers, including pharma/biotech, are appropriately compensated for time, effort, R&D, etc. What’s the right balance for patients, HCPs, the healthcare system? Let’s keep these questions coming and open, collaborative convos going.

  • There has to be a cost effective way to find treatments for cancer in the future. I completely understand there is a cost of research, but there will be a lot of good people lost with a million dollar cost.

  • If we don’t focus on making the benefits of innovations such as CAR-T cell therapy available to all at lower costs, the health disparity between rich and poor Americans will only grow wider. The rich will be healthier and live longer while the poor will be sicker and have shorter life spans.

    Consider

    If we don’t focus on making the benefits of innovations such as CAR-T cell therapy available to all at lower costs, the health disparity between rich and poor Americans will only grow wider. The rich will be healthier and live longer while the poor will be sicker and have shorter life spans.

    Consider women’s health today...I know a school teacher who has breast cancer but can’t afford to take time off and struggles balancing teaching and gong through her chemotherapy sessions. I know an investment banker who has breast cancer and is able to take a year off from work to just focus on getting her treatments and getting better. This is the health disparity we live with today.

  • Competition isn’t driving down healthcare costs. Instead the big pharmaceutical companies hide behind regulatory safety. Price controls and single payer healthcare seem to be the only effective measure to keep costs at bay and even that suffers from private insurance lobbyists doing what they can to sabotage those systems.

  • Unfortunately this is just another scenario of the extreme commodification of healthcare, something that should be considered a human right. Healthcare is a mechanism of this society that increasingly fosters the survival of the elite and wealthy.